Table 2.
All (n=515) | HFpEF (n=124) | AF (n=193) | HFpEF+AF (n=198) | p value | |
LV EDD, mm | 46 ± 5 | 46 ± 5 | 46 ±5 | 46 ± 5 | 0.59 |
LV ESD, mm | 30 ± 4 | 30 ± 4 | 31 ± 4 | 31 ± 5 | 0.80 |
LV mass, g | 177 ± 47 | 178 ± 49 | 177 ± 48 | 177 ± 46 | 0.97 |
LV mass index, g/h 2.7 | 43 ± 10 | 45 ± 12 | 42 ± 8† | 44 ± 11 | 0.03 |
LV hypertrophy | 31 % | 40 % | 22 % | 33 % | 0.009 |
LV relative wall thickness | 0.45 ± 0.09 | 0.45 ± 0.1 | 0.45 ± 0.08 | 0.46 ± 0.09 | 0.23 |
LV concentric geometry | 57 % | 58 % | 54 % | 59 % | 0.63 |
LV EDV, ml | 117 ± 35 | 124 ± 34 | 120 ± 36 | 110 ± 33† | 0.001 |
LV EF, % | 65 ± 7 | 66 ± 7 | 65 ± 7 | 64 ± 8† | 0.03 |
LV GLS, % | −17.3 ± 4.1 | −19.0 ± 3.9* | −16.7 ± 4.0 | −16.9 ± 4.0 | <0.001 |
Low GLS | 50 % | 32 % | 55 % | 57 % | <0.001 |
LV GCS, % | −26.8 ± 5.5 | −28.4 ± 5.0‡ | −25.5 ± 5.3* | −27.0 ± 5.6‡ | <0.001 |
Dilated right ventricle § | 17 % | 9 % | 15 % | 23 % | 0.04 |
Right ventricular systolic dysfunction § | 7 % | 6 % | 4 % | 10 % | 0.16 |
Mild/moderate tricuspid regurgitation | 82 % | 74 % | 83 % | 83 % | <0.001 |
Estimated SPAP, mmHg | 45 ± 13 | 49 ± 16‡ | 41 ± 9 | 46 ± 13‡ | <0.001 |
Values are mean ± standard deviation or percentage. The p value in the last table column indicates the statistical significance when testing the overall group differences (by ANOVA for continuous variables and chi-square or Fisheŕs exact test for categorical variables).
p < 0.05 vs. all the other groups by Sidaks′ posthoc test.
p < 0.05 vs. the HFpEF group by Sidaks′ posthoc test.
p < 0.05 vs. the AF group by Sidaks′ posthoc test.
Based on qualitative assessment.
AF = atrial fibrillation; EDD = end-diastolic diameter; EDV = end-diastolic volume; EF = ejection fraction; ESD = end-systolic diameter; GCS = global circumferential strain; GLS = global longitudinal strain; HFpEF = heart failure with preserved ejection fraction; LV = left ventricular; SPAP = systolic pulmonary artery pressure.